4//SEC Filing
Stewart Robert A 4
Accession 0001723128-19-000088
CIK 0001723128other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:43 PM ET
Size
8.8 KB
Accession
0001723128-19-000088
Insider Transaction Report
Form 4
Stewart Robert A
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2019-05-07+83,277→ 100,277 total - Exercise/Conversion
Restricted Stock Units
2019-05-07−83,277→ 249,834 total→ Class A Common Stock (83,277 underlying) - Tax Payment
Class A Common Stock
2019-05-07$13.44/sh−21,609$290,425→ 78,668 total
Footnotes (4)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]On May 7, 2018, the reporting person was granted 333,111 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001476493
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:43 PM ET
- Size
- 8.8 KB